<?xml version="1.0" encoding="UTF-8"?>
<p class="p">The Ml EtOAcF up to the dose of 800 mg/kg BW did not produce any signs of adverse reactions and no changes on the behavior of the treated animals up to 14 days following the extract administration. The treated animals did not display any abnormal signs such as food and water intake, convulsions, salivation, or diarrhea. No deaths or weight losses were recorded during the study. Therefore, the Ml EtOAcF at 200 mg/Kg BW was used in the
 <italic class="italic"> in vivo</italic> investigation of the anti-inflammatory activity.
</p>
